Home/Filings/4/0001209191-20-036845
4//SEC Filing

5AM Ventures IV, L.P. 4

Accession 0001209191-20-036845

CIK 0001781983other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 9:12 PM ET

Size

19.9 KB

Accession

0001209191-20-036845

Insider Transaction Report

Form 4
Period: 2020-06-11
Transactions
  • Sale

    Common Stock

    2020-06-11$28.75/sh9,800$281,77680,772 total(indirect: See footnotes)
  • Sale

    Common Stock

    2020-06-11$28.75/sh235,200$6,762,6351,938,549 total(indirect: See footnotes)
Holdings
  • Common Stock

    (indirect: See footnotes)
    333,333
Footnotes (5)
  • [F1]Shares are held directly by 5AM Ventures IV, L.P.
  • [F2]5AM Partners IV, LLC is the sole general partner of each of 5AM Ventures IV, L.P. and 5AM Co-Investors IV, L.P. (collectively, the "5AM IV Funds"). Dr. John D. Diekman, Andrew J. Schwab and Dr. Scott M. Rocklage are managing members of 5AM Partners IV, LLC and may be deemed to have shared voting and investment power over the shares beneficially owned by the 5AM IV Funds. Each of 5AM Partners IV, LLC, Dr. Diekman, Mr. Schwab and Dr. Rocklage disclaims beneficial ownership of the shares of Common Stock and Preferred Stock held directly by the 5AM IV Funds, except to the extent of its or his pecuniary interest therein.
  • [F3]Shares are held directly by 5AM Co-Investors IV, L.P.
  • [F4]Shares are held directly by 5AM Opportunities I, L.P. ("Opportunities"), which is under common control with the 5AM IV Funds. The 5AM IV Funds and Opportunities expressly disclaim status as a "group" for purposes of this Form 4.
  • [F5]5AM Opportunities I (GP), LLC ("Opportunities GP") is the sole general partner of Opportunities. Andrew J. Schwab and Dr. Kush Parmar are managing members of Opportunities GP and may be deemed to have shared voting and investment power over the shares beneficially owned by Opportunities. Each of Opportunities GP, Mr. Schwab and Dr. Parmar disclaims beneficial ownership of the shares of Common Stock held directly by Opportunities, except to the extent of its or his pecuniary interest therein.

Issuer

Aprea Therapeutics, Inc.

CIK 0001781983

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001589315

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 9:12 PM ET
Size
19.9 KB